货号:A185961 同义名: UCB L059;SIB-S1
Levetiracetam is an anticonvulsant with antihyperalgesic efficacy in inflammatory pain. It binds the synaptic vesicle protein SV2A (pIC50 = 5.7), presumably altering vesicle exocytosis.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Levetiracetam is an anticonvulsant with antihyperalgesic efficacy in inflammatory pain. It binds the synaptic vesicle protein SV2A (pIC50 = 5.7), presumably altering vesicle exocytosis. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01392768 | Epilepsy Part... 展开 >>ial Seizures 收起 << | Phase 3 | Completed | - | - |
NCT00413296 | Post-Traumatic Stress Disorder | Phase 2 Phase 3 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27705 收起 << |
NCT00826865 | Seizures | Not Applicable | Completed | - | United States, Arizona ... 展开 >> MDS Pharma Services Phoenix, Arizona, United States, 85044 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
5.88mL 1.18mL 0.59mL |
29.38mL 5.88mL 2.94mL |
58.75mL 11.75mL 5.88mL |
CAS号 | 102767-28-2 |
分子式 | C8H14N2O2 |
分子量 | 170.21 |
别名 | UCB L059;SIB-S1;Levetiracetam, Keppra, Etiracetam, UCB 6474 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,Room Temperature |
溶解度 |
DMSO: 90 mg/mL(528.76 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 85 mg/mL(499.39 mM) |
动物实验配方 |